MEVIS MEDSOL N - Dusseldorf Stock Exchang
MEVIS MEDSOL N - Dusseldorf Stock Exchang operates in Diversified Metals & Mining.
MEVIS MEDSOL N - Dusseldorf Stock Exchang (M3V) - Total Liabilities
Latest total liabilities as of March 2024: €7.30 Million EUR
Based on the latest financial reports, MEVIS MEDSOL N - Dusseldorf Stock Exchang (M3V) has total liabilities worth €7.30 Million EUR as of March 2024.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
MEVIS MEDSOL N - Dusseldorf Stock Exchang - Total Liabilities Trend (2017–2023)
This chart illustrates how MEVIS MEDSOL N - Dusseldorf Stock Exchang's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
MEVIS MEDSOL N - Dusseldorf Stock Exchang Competitors by Total Liabilities
The table below lists competitors of MEVIS MEDSOL N - Dusseldorf Stock Exchang ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
CBRAIN
BE:C6F
|
Germany | €111.68 Million |
|
Prima Moda SA
WAR:PMA
|
Poland | zł10.61 Million |
|
The Yumy Candy Company Inc
OTCQB:YUMFF
|
USA | $3.41 Million |
|
Boussard & Gavaudan Holding Limited
LSE:BGHL
|
UK | €2.08 Million |
|
CompuLab Ltd
TA:CLAB
|
Israel | ILA24.65 Million |
|
ANGLO AMERICAN
MU:NGLB
|
Germany | €34.93 Billion |
Liability Composition Analysis (2017–2023)
This chart breaks down MEVIS MEDSOL N - Dusseldorf Stock Exchang's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.80 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.41 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.29 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how MEVIS MEDSOL N - Dusseldorf Stock Exchang's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for MEVIS MEDSOL N - Dusseldorf Stock Exchang (2017–2023)
The table below shows the annual total liabilities of MEVIS MEDSOL N - Dusseldorf Stock Exchang from 2017 to 2023.
| Year | Total Liabilities | Change |
|---|---|---|
| 2023-09-30 | €10.23 Million | -23.53% |
| 2022-09-30 | €13.38 Million | +37.78% |
| 2021-09-30 | €9.71 Million | -2.58% |
| 2020-09-30 | €9.96 Million | +63.53% |
| 2019-09-30 | €6.09 Million | -4.19% |
| 2018-09-30 | €6.36 Million | -61.61% |
| 2017-09-30 | €16.57 Million | -- |